CN Stock MarketDetailed Quotes

000403 Pacific Shuanglin Bio-pharmacy

Watchlist
  • 26.66
  • -1.24-4.44%
Market Closed Jul 12 15:00 CST
19.54BMarket Cap28.85P/E (TTM)

Pacific Shuanglin Bio-pharmacy Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
67.00%435.64M
-3.18%2.33B
-7.95%1.37B
-28.45%709.07M
-47.87%260.86M
21.98%2.41B
11.27%1.49B
25.35%991.05M
75.67%500.42M
87.80%1.97B
Operating revenue
67.00%435.64M
-3.18%2.33B
-7.95%1.37B
-28.45%709.07M
-47.87%260.86M
21.98%2.41B
11.27%1.49B
25.35%991.05M
75.67%500.42M
87.80%1.97B
Other operating revenue
----
-65.97%3.27M
----
335.96%2.49M
----
82.15%9.59M
----
246.63%571.6K
----
-29.20%5.27M
Total operating cost
36.27%297.49M
-6.49%1.64B
-6.64%1.03B
-22.60%572.35M
-43.22%218.31M
17.88%1.75B
11.09%1.11B
24.83%739.46M
71.40%384.46M
78.61%1.49B
Operating cost
57.26%211.64M
-1.87%1.13B
-8.63%686.74M
-30.32%363.42M
-50.55%134.58M
8.29%1.15B
6.50%751.61M
23.14%521.57M
66.69%272.16M
97.88%1.06B
Operating tax surcharges
61.35%4.54M
29.15%21.69M
10.16%11.71M
-6.43%6.63M
-27.56%2.81M
9.93%16.8M
2.49%10.63M
12.40%7.09M
58.13%3.88M
112.43%15.28M
Operating expense
-18.05%33.96M
-28.53%285.57M
-7.01%202.26M
-5.81%121.01M
-40.66%41.43M
74.28%399.57M
41.68%217.51M
56.60%128.47M
147.28%69.82M
44.54%229.27M
Administration expense
2.78%39.94M
8.93%180.25M
-0.08%121.65M
-1.63%81.31M
6.04%38.86M
-12.78%165.48M
-11.25%121.75M
-0.74%82.65M
20.66%36.65M
61.42%189.73M
Financial expense
1.42%-13.46M
-4.08%-57.57M
-10.24%-42.85M
-14.82%-29.39M
-8.11%-13.65M
-20.83%-55.31M
-13.42%-38.87M
-24.73%-25.6M
-75.21%-12.63M
-4,380.98%-45.78M
-Interest expense (Financial expense)
-18.25%2.01M
-19.96%9.63M
-24.14%6.2M
-21.33%4.47M
-8.83%2.46M
11.60%12.03M
-14.43%8.17M
-31.46%5.69M
-53.38%2.7M
-44.20%10.78M
-Interest Income (Financial expense)
4.55%-15.69M
-3.84%-67.68M
-3.00%-50.32M
-7.24%-34.08M
-6.25%-16.44M
-11.24%-65.18M
-11.43%-48.85M
-10.10%-31.78M
-18.90%-15.47M
-220.10%-58.59M
Research and development
46.17%20.86M
5.73%79.69M
21.84%53.76M
16.25%29.37M
-2.06%14.27M
111.52%75.36M
85.63%44.12M
42.39%25.27M
103.31%14.57M
224.02%35.63M
Credit Impairment Loss
-88.05%1.44M
127.17%3.21M
291.92%8.07M
310.76%8.97M
2,764.23%12.06M
-25.20%-11.82M
33.48%-4.2M
-31.64%-4.26M
-583.30%-452.73K
-355.91%-9.44M
Asset Impairment Loss
----
----
----
----
----
100.12%124.41K
----
----
----
-1,875.37%-103.68M
Other net revenue
-46.86%10.96M
-48.51%5.96M
170.58%31.09M
1,334.39%24.64M
397.92%20.62M
148.49%11.58M
109.73%11.49M
-62.99%1.72M
4.72%4.14M
-862.40%-23.87M
Fair value change income
-254.95%-4.24M
-484.85%-18.97M
217.43%8.95M
1,546.93%5.66M
87.47%2.74M
-93.36%4.93M
--2.82M
--343.43K
--1.46M
--74.21M
Invest income
1,301.96%8.65M
143.66%7.4M
65.46%4.36M
62.56%2.59M
-44.95%616.69K
-17.92%3.04M
-47.87%2.63M
-41.76%1.6M
137.37%1.12M
--3.7M
Asset deal income
110,562.94%595.4K
-224.40%-544.96K
-97.25%12.02K
237.07%12.02K
-85.90%538.03
64.53%438.08K
890.65%437.78K
-109.78%-8.77K
115.70%3.82K
993.62%266.27K
Other revenue
-13.31%4.52M
-0.01%14.86M
-0.95%9.71M
83.24%7.41M
158.96%5.21M
34.24%14.86M
46.30%9.8M
-19.86%4.04M
-43.72%2.01M
137.23%11.07M
Operating profit
136.04%149.11M
4.79%695.19M
-6.42%372.64M
-36.30%161.36M
-47.40%63.17M
44.09%663.43M
13.33%398.21M
24.86%253.31M
86.17%120.1M
109.00%460.43M
Add:Non operating Income
56,550.50%107.88K
40.42%3.53M
2,240.22%3.28M
668.70%1.08M
15,509.02%190.43
369.58%2.52M
198.87%140.3K
275.39%139.86K
-99.99%1.22
-6.24%535.63K
Less:Non operating expense
3,121.51%8.27M
91.09%10.61M
221.78%5.85M
109.80%3.11M
-77.22%256.78K
88.10%5.55M
262.82%1.82M
336.78%1.48M
500.34%1.13M
-19.66%2.95M
Total profit
124.03%140.95M
4.20%688.11M
-6.67%370.07M
-36.77%159.33M
-47.12%62.92M
44.19%660.39M
12.99%396.54M
24.38%251.97M
84.93%118.98M
110.88%458.01M
Less:Income tax cost
184.83%19.08M
5.41%76.64M
-3.77%44.26M
-46.25%16.33M
-48.36%6.7M
9.37%72.7M
-1.20%45.99M
15.89%30.38M
60.43%12.97M
92.62%66.47M
Net profit
116.78%121.87M
4.05%611.47M
-7.06%325.81M
-35.47%143M
-46.97%56.22M
50.10%587.69M
15.16%350.55M
25.64%221.59M
88.45%106M
114.33%391.54M
Net profit from continuing operation
116.78%121.87M
4.05%611.47M
-7.06%325.81M
-35.47%143M
-46.97%56.22M
50.10%587.69M
15.16%350.55M
25.64%221.59M
88.45%106M
114.33%391.54M
Less:Minority Profit
50.02%-78.85K
-214.31%-638.57K
-138.00%-382.1K
-123.26%-136.17K
-139.51%-157.77K
17.35%558.65K
110.10%1.01M
43.67%585.52K
361.96%399.29K
114.51%476.06K
Net profit of parent company owners
116.31%121.95M
4.25%612.11M
-6.68%326.2M
-35.23%143.14M
-46.62%56.38M
50.14%587.13M
15.01%349.54M
25.60%221.01M
87.24%105.6M
110.29%391.06M
Earning per share
Basic earning per share
116.47%0.1669
4.34%0.8384
-6.77%0.446
-35.29%0.1958
-46.68%0.0771
44.96%0.8035
9.90%0.4784
17.29%0.3026
62.29%0.1446
45.98%0.5543
Diluted earning per share
116.47%0.1669
4.38%0.8384
-6.69%0.446
-35.25%0.1958
-46.61%0.0771
45.24%0.8032
10.09%0.478
17.48%0.3024
62.80%0.1444
45.79%0.553
Other composite income
111.10%1.01K
-69.03%11.04K
-72.62%20.99K
154.34%25.57K
-254.99%-9.14K
36,365.92%35.64K
76.65K
10.05K
5.9K
-98.28
Other composite income of parent company owners
111.10%1.01K
-69.03%11.04K
-72.62%20.99K
154.34%25.57K
-254.99%-9.14K
36,365.92%35.64K
--76.65K
--10.05K
--5.9K
---98.28
Total composite income
116.82%121.87M
4.04%611.48M
-7.07%325.83M
-35.46%143.03M
-46.98%56.21M
50.11%587.73M
15.19%350.62M
25.65%221.6M
88.46%106.01M
114.33%391.54M
Total composite income of parent company owners
116.35%121.95M
4.25%612.12M
-6.69%326.22M
-35.23%143.16M
-46.63%56.37M
50.15%587.17M
15.04%349.62M
25.61%221.02M
87.25%105.61M
110.29%391.06M
Total composite income of minority owners
50.02%-78.85K
-214.31%-638.57K
-138.00%-382.1K
-123.26%-136.17K
-139.51%-157.77K
17.35%558.65K
110.10%1.01M
43.67%585.52K
361.96%399.29K
114.51%476.06K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 67.00%435.64M-3.18%2.33B-7.95%1.37B-28.45%709.07M-47.87%260.86M21.98%2.41B11.27%1.49B25.35%991.05M75.67%500.42M87.80%1.97B
Operating revenue 67.00%435.64M-3.18%2.33B-7.95%1.37B-28.45%709.07M-47.87%260.86M21.98%2.41B11.27%1.49B25.35%991.05M75.67%500.42M87.80%1.97B
Other operating revenue -----65.97%3.27M----335.96%2.49M----82.15%9.59M----246.63%571.6K-----29.20%5.27M
Total operating cost 36.27%297.49M-6.49%1.64B-6.64%1.03B-22.60%572.35M-43.22%218.31M17.88%1.75B11.09%1.11B24.83%739.46M71.40%384.46M78.61%1.49B
Operating cost 57.26%211.64M-1.87%1.13B-8.63%686.74M-30.32%363.42M-50.55%134.58M8.29%1.15B6.50%751.61M23.14%521.57M66.69%272.16M97.88%1.06B
Operating tax surcharges 61.35%4.54M29.15%21.69M10.16%11.71M-6.43%6.63M-27.56%2.81M9.93%16.8M2.49%10.63M12.40%7.09M58.13%3.88M112.43%15.28M
Operating expense -18.05%33.96M-28.53%285.57M-7.01%202.26M-5.81%121.01M-40.66%41.43M74.28%399.57M41.68%217.51M56.60%128.47M147.28%69.82M44.54%229.27M
Administration expense 2.78%39.94M8.93%180.25M-0.08%121.65M-1.63%81.31M6.04%38.86M-12.78%165.48M-11.25%121.75M-0.74%82.65M20.66%36.65M61.42%189.73M
Financial expense 1.42%-13.46M-4.08%-57.57M-10.24%-42.85M-14.82%-29.39M-8.11%-13.65M-20.83%-55.31M-13.42%-38.87M-24.73%-25.6M-75.21%-12.63M-4,380.98%-45.78M
-Interest expense (Financial expense) -18.25%2.01M-19.96%9.63M-24.14%6.2M-21.33%4.47M-8.83%2.46M11.60%12.03M-14.43%8.17M-31.46%5.69M-53.38%2.7M-44.20%10.78M
-Interest Income (Financial expense) 4.55%-15.69M-3.84%-67.68M-3.00%-50.32M-7.24%-34.08M-6.25%-16.44M-11.24%-65.18M-11.43%-48.85M-10.10%-31.78M-18.90%-15.47M-220.10%-58.59M
Research and development 46.17%20.86M5.73%79.69M21.84%53.76M16.25%29.37M-2.06%14.27M111.52%75.36M85.63%44.12M42.39%25.27M103.31%14.57M224.02%35.63M
Credit Impairment Loss -88.05%1.44M127.17%3.21M291.92%8.07M310.76%8.97M2,764.23%12.06M-25.20%-11.82M33.48%-4.2M-31.64%-4.26M-583.30%-452.73K-355.91%-9.44M
Asset Impairment Loss --------------------100.12%124.41K-------------1,875.37%-103.68M
Other net revenue -46.86%10.96M-48.51%5.96M170.58%31.09M1,334.39%24.64M397.92%20.62M148.49%11.58M109.73%11.49M-62.99%1.72M4.72%4.14M-862.40%-23.87M
Fair value change income -254.95%-4.24M-484.85%-18.97M217.43%8.95M1,546.93%5.66M87.47%2.74M-93.36%4.93M--2.82M--343.43K--1.46M--74.21M
Invest income 1,301.96%8.65M143.66%7.4M65.46%4.36M62.56%2.59M-44.95%616.69K-17.92%3.04M-47.87%2.63M-41.76%1.6M137.37%1.12M--3.7M
Asset deal income 110,562.94%595.4K-224.40%-544.96K-97.25%12.02K237.07%12.02K-85.90%538.0364.53%438.08K890.65%437.78K-109.78%-8.77K115.70%3.82K993.62%266.27K
Other revenue -13.31%4.52M-0.01%14.86M-0.95%9.71M83.24%7.41M158.96%5.21M34.24%14.86M46.30%9.8M-19.86%4.04M-43.72%2.01M137.23%11.07M
Operating profit 136.04%149.11M4.79%695.19M-6.42%372.64M-36.30%161.36M-47.40%63.17M44.09%663.43M13.33%398.21M24.86%253.31M86.17%120.1M109.00%460.43M
Add:Non operating Income 56,550.50%107.88K40.42%3.53M2,240.22%3.28M668.70%1.08M15,509.02%190.43369.58%2.52M198.87%140.3K275.39%139.86K-99.99%1.22-6.24%535.63K
Less:Non operating expense 3,121.51%8.27M91.09%10.61M221.78%5.85M109.80%3.11M-77.22%256.78K88.10%5.55M262.82%1.82M336.78%1.48M500.34%1.13M-19.66%2.95M
Total profit 124.03%140.95M4.20%688.11M-6.67%370.07M-36.77%159.33M-47.12%62.92M44.19%660.39M12.99%396.54M24.38%251.97M84.93%118.98M110.88%458.01M
Less:Income tax cost 184.83%19.08M5.41%76.64M-3.77%44.26M-46.25%16.33M-48.36%6.7M9.37%72.7M-1.20%45.99M15.89%30.38M60.43%12.97M92.62%66.47M
Net profit 116.78%121.87M4.05%611.47M-7.06%325.81M-35.47%143M-46.97%56.22M50.10%587.69M15.16%350.55M25.64%221.59M88.45%106M114.33%391.54M
Net profit from continuing operation 116.78%121.87M4.05%611.47M-7.06%325.81M-35.47%143M-46.97%56.22M50.10%587.69M15.16%350.55M25.64%221.59M88.45%106M114.33%391.54M
Less:Minority Profit 50.02%-78.85K-214.31%-638.57K-138.00%-382.1K-123.26%-136.17K-139.51%-157.77K17.35%558.65K110.10%1.01M43.67%585.52K361.96%399.29K114.51%476.06K
Net profit of parent company owners 116.31%121.95M4.25%612.11M-6.68%326.2M-35.23%143.14M-46.62%56.38M50.14%587.13M15.01%349.54M25.60%221.01M87.24%105.6M110.29%391.06M
Earning per share
Basic earning per share 116.47%0.16694.34%0.8384-6.77%0.446-35.29%0.1958-46.68%0.077144.96%0.80359.90%0.478417.29%0.302662.29%0.144645.98%0.5543
Diluted earning per share 116.47%0.16694.38%0.8384-6.69%0.446-35.25%0.1958-46.61%0.077145.24%0.803210.09%0.47817.48%0.302462.80%0.144445.79%0.553
Other composite income 111.10%1.01K-69.03%11.04K-72.62%20.99K154.34%25.57K-254.99%-9.14K36,365.92%35.64K76.65K10.05K5.9K-98.28
Other composite income of parent company owners 111.10%1.01K-69.03%11.04K-72.62%20.99K154.34%25.57K-254.99%-9.14K36,365.92%35.64K--76.65K--10.05K--5.9K---98.28
Total composite income 116.82%121.87M4.04%611.48M-7.07%325.83M-35.46%143.03M-46.98%56.21M50.11%587.73M15.19%350.62M25.65%221.6M88.46%106.01M114.33%391.54M
Total composite income of parent company owners 116.35%121.95M4.25%612.12M-6.69%326.22M-35.23%143.16M-46.63%56.37M50.15%587.17M15.04%349.62M25.61%221.02M87.25%105.61M110.29%391.06M
Total composite income of minority owners 50.02%-78.85K-214.31%-638.57K-138.00%-382.1K-123.26%-136.17K-139.51%-157.77K17.35%558.65K110.10%1.01M43.67%585.52K361.96%399.29K114.51%476.06K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg